VST
GILD icon

Van Strum & Towne’s Gilead Sciences GILD Stock Holding History

Van Strum & Towne’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,887
Closed -$2.67M – 108
2024
Q3 		$2.67M Sell
31,887
-350
-1% -$26.7K 0.93% 29
2024
Q2 		$2.21M Sell
32,237
-775
-2% -$51.7K 0.8% 33
2024
Q1 		$2.42M Sell
33,012
-1,950
-6% -$150K 0.88% 31
2023
Q4 		$2.83M Sell
34,962
-350
-1% -$27.2K 1.11% 28
2023
Q3 		$2.65M Sell
35,312
-370
-1% -$28.5K 1.12% 27
2023
Q2 		$2.75M Sell
35,682
-50
-0.1% -$3.99K 1.14% 25
2023
Q1 		$2.96M Buy
35,732
+165
+0.5% +$13.7K 1.27% 23
2022
Q4 		$3.05M Buy
35,567
+60
+0.2% +$4.75K 1.31% 26
2022
Q3 		$2.19M Sell
35,507
-447
-1% -$28.2K 1.01% 28
2022
Q2 		$2.22M Sell
35,954
-248
-0.7% -$15.4K 0.95% 28
2022
Q1 		$2.15M Buy
36,202
+200
+0.6% +$12.8K 0.81% 31
2021
Q4 		$2.61M Sell
36,002
-225
-0.6% -$15.5K 0.95% 27
2021
Q3 		$2.53M Sell
36,227
-125
-0.3% -$8.78K 1% 28
2021
Q2 		$2.5M Sell
36,352
-620
-2% -$41.4K 1.2% 23
2021
Q1 		$2.39M Sell
36,972
-785
-2% -$50.6K 1.21% 23
2020
Q4 		$2.2M Sell
37,757
-1,225
-3% -$73.9K 1.22% 23
2020
Q3 		$2.46M Buy
38,982
+400
+1% +$27.7K 1.6% 18
2020
Q2 		$2.97M Sell
38,582
-100
-0.3% -$7.66K 2.07% 16
2020
Q1 		$2.89M Buy
38,682
+548
+1% +$37.9K 2.29% 13
2019
Q4 		$2.48M Buy
38,134
+155
+0.4% +$10.1K 1.53% 21
2019
Q3 		$2.41M Buy
37,979
+2,380
+7% +$156K 1.59% 22
2019
Q2 		$2.4M Sell
35,599
-735
-2% -$48.4K 1.71% 22
2019
Q1 		$2.36M Sell
36,334
-275
-0.8% -$18.3K 1.76% 22
2018
Q4 		$2.29M Sell
36,609
-4,186
-10% -$293K 1.93% 22
2018
Q3 		$3.15M Hold
40,795
– – 2.03% 21
2018
Q2 		$2.89M Sell
40,795
-602
-1% -$42.5K 2% 23
2018
Q1 		$3.12M Sell
41,397
-513
-1% -$40.8K 2.19% 20
2017
Q4 		$3M Sell
41,910
-10,870
-21% -$825K 2% 24
2017
Q3 		$4.28M Buy
52,780
+1,005
+2% +$76.8K 2.78% 14
2017
Q2 		$3.67M Sell
51,775
-250
-0.5% -$16.6K 2.39% 17
2017
Q1 		$3.53M Buy
52,025
+16,898
+48% +$1.19M 2.28% 19
2016
Q4 		$2.52M Sell
35,127
-2,710
-7% -$201K 1.58% 28
2016
Q3 		$2.99M Buy
37,837
+330
+0.9% +$26.8K 1.97% 23
2016
Q2 		$3.13M Buy
37,507
+2
+0% +$177 2.08% 21
2016
Q1 		$3.44M Buy
37,505
+950
+3% +$85.7K 2.28% 19
2015
Q4 		$3.7M Buy
36,555
+610
+2% +$63.5K 2.4% 17
2015
Q3 		$3.53M Buy
35,945
+40
+0.1% +$4.44K 2.41% 16
2015
Q2 		$4.2M Hold
35,905
– – 2.59% 16
2015
Q1 		$3.52M Buy
35,905
+18,620
+108% +$1.89M 2.19% 20
2014
Q4 		$1.63M Buy
17,285
+65
+0.4% +$6.72K 1.01% 35
2014
Q3 		$1.83M Buy
17,220
+315
+2% +$30.8K 1.2% 33
2014
Q2 		$1.4M Buy
+16,905
New +$1.32M 0.92% 38

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Van Strum & Towne's GILD Position: Q4 2024 in Review

Van Strum & Towne sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 31,887 shares — an estimated $2.67M sold.

Van Strum & Towne first reported a position in GILD in Q2 2014 and held it in 42 quarters. The position peaked at $4.28M in Q3 2017. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Van Strum & Towne reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Van Strum & Towne sold 31,887 Gilead Sciences shares in Q4 2024, an estimated $2.67M.
  • Van Strum & Towne first reported a position in Gilead Sciences in Q2 2014 and held it in 42 quarters.
  • Van Strum & Towne's Gilead Sciences position peaked at $4.28M in Q3 2017.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Van Strum & Towne's 13F filing for Q4 2024, filed 10 Feb 2025.